Selenium Exposure and Cancer Risk: An Updated Meta-analysis and Meta-regression

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Cai, Xianlei ^a,b   Wang, Chen ^a   Yu, Wanqi ^a   Fan, Wenjie ^a   Wang, Shan ^a   Shen, Ning ^a   Wu, Pengcheng ^a   Li, Xiuyang ^a   Wang, Fudi ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Lihuili Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM;

BLOOD; CHEMISTRY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MALE; META ANALYSIS; NAIL; NEOPLASMS; ODDS RATIO; RISK ASSESSMENT;

ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; NAILS; NEOPLASMS; ODDS RATIO; RISK ASSESSMENT; SELENIUM;

EID: 84955134955     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19213     Document Type: Article

References (99)

1. Roman, M., Jitaru, P., Barbante, C. Selenium Biochemistry and its Role for Human Health. Metallomics. 6,25-54 (2013).
2. Rayman, M. P. Selenium and Human Health. Lancet. 379, 1256-1268 (2012).
3. Tanguy, S., Grauzam, S., de Leiris, J., Boucher, F. Impact of Dietary Selenium Intake On Cardiac Health: Experimental Approaches and Human Studies. Mol Nutr Food Res. 56, 1106-1121 (2012).
4. Berthold, H. K., Michalke, B., Krone, W., Guallar, E., Gouni-Berthold, I. Influence of Serum Selenium Concentrations On Hypertension: The Lipid Analytic Cologne Cross-Sectional Study. J Hypertens. 30, 1328-1335 (2012).
5. Rees, K. et al. Selenium Supplementation for the Primary Prevention of Cardiovascular Disease. Cochrane Database Syst Rev. 1, D9671 (2013).
6. Vinceti, M. et al. Cerebrospinal Fluid of Newly Diagnosed Amyotrophic Lateral Sclerosis Patients Exhibits Abnormal Levels of Selenium Species Including Elevated Selenite. Neurotoxicology. 38, 25-32 (2013).
7. Park, K. et al. Toenail Selenium and Incidence of Type 2 Diabetes in U.S. Men and Women. Diabetes Care. 35, 1544-1551 (2012).
8. Stranges, S. et al. A Prospective Study of Dietary Selenium Intake and Risk of Type 2 Diabetes. BMC Public Health. 10, 564 (2010).
9. Bleys, J., Navas-Acien, A., Guallar, E. Serum Selenium and Diabetes in U.S. Adults. Diabetes Care. 30, 829-834 (2007).
10. Rajpathak, S., Rimm, E., Morris, J. S., Hu, F. Toenail Selenium and Cardiovascular Disease in Men with Diabetes. J Am Coll Nutr. 24, 250-256 (2005).
11. Vinceti, M. et al. Selenium for Preventing Cancer. Cochrane Database Syst Rev. 3, D5195 (2014).
12. Stang, A. Critical Evaluation of the Newcastle-Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta-Analyses. Eur J Epidemiol. 25, 603-605 (2010).
13. Wells, G. A., B. S. D. O. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Secondary the Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. (2011) Http://Www.Ohri.Ca/Programs/Clinical-Epidemiology/Oxford.Asp. (2014-03-10).
14. Higgins, J. P., Green, S. Cochrane Handbook for Systematic Reviews of Interventions Version5.1.0 [Updated March 2011]. (2011) http://handbook.cochrane.org/. (2014-03-12).
15. Greenland, S., Longnecker, M. P. Methods for Trend Estimation From Summarized Dose-Response Data, with Applications to Meta-Analysis. Am J Epidemiol. 135, 1301-1309 (1992).
16. Orsini, N., Li, R., Wolk, A., Khudyakov, P., Spiegelman, D. Meta-Analysis for Linear and Nonlinear Dose-Response Relations: Examples, an Evaluation of Approximations, and Software. Am J Epidemiol. 175, 66-73 (2012).
17. Higgins, J. P., Thompson, S. G. Quantifying Heterogeneity in a Meta-Analysis. Stat Med. 21, 1539-1558 (2002).
18. Higgins, J. P., Thompson, S. G., Deeks, J. J., Altman, D. G. Measuring Inconsistency in Meta-Analyses. BMJ. 327, 557-560 (2003).
19. Mantel, N., Haenszel, W. Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease. J Natl Cancer Inst. 22, 719-748 (1959).
20. DerSimonian, R., Laird, N. Meta-Analysis in Clinical Trials. Control Clin Trials. 7, 177-188 (1986).
21. Begg, C. B., Mazumdar, M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics. 50, 1088-1101 (1994).
22. Egger, M., Smith, G. D. Bias in Location and Selection of Studies. BMJ. 316, 61-66 (1998).
23. Ghadirian, P. et al. A Case-Control Study of Toenail Selenium and Cancer of the Breast, Colon, and Prostate. Cancer Detect Prev. 24, 305-313 (2000).
24. Knekt, P. et al. Serum Selenium and Subsequent Risk of Cancer Among Finnish Men and Women. J Natl Cancer Inst. 82, 864-868 (1990).
25. Garland, M. et al. Prospective Study of Toenail Selenium Levels and Cancer Among Women. J Natl Cancer Inst. 87, 497-505 (1995).
26. Kabuto, M. et al. Prediagnostic Serum Selenium and Zinc Levels and Subsequent Risk of Lung and Stomach Cancer in Japan. Cancer Epidemiol Biomarkers Prev. 3, 465-469 (1994).
27. Lippman, S. M. et al. Effect of Selenium and Vitamin E On Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 301, 39-51 (2009).
28. Clark, L. C. et al. Effects of Selenium Supplementation for Cancer Prevention in Patients with Carcinoma of the Skin. A Randomized Controlled Trial. Nutritional Prevention of Cancer Study Group. JAMA. 276, 1957-1963 (1996).
29. Steevens, J., van den Brandt, P. A., Goldbohm, R. A., Schouten, L. J. Selenium Status and the Risk of Esophageal and Gastric Cancer Subtypes: The Netherlands Cohort Study. Gastroenterology. 138, 1704-1713 (2010).
30. Wei, W. Q. et al. Prospective Study of Serum Selenium Concentrations and Esophageal and Gastric Cardia Cancer, Heart Disease, Stroke, and Total Death. Am J Clin Nutr. 79, 80-85 (2004).
31. Mark, S. D. et al. Prospective Study of Serum Selenium Levels and Incident Esophageal and Gastric Cancers. J Natl Cancer Inst. 92, 1753-1763 (2000).
32. van den Brandt, P. A. et al. A Prospective Cohort Study On Toenail Selenium Levels and Risk of Gastrointestinal Cancer. J Natl Cancer Inst. 85, 224-229 (1993).
33. Goodman, G. E., Schaffer, S., Bankson, D. D., Hughes, M. P., Omenn, G. S. Predictors of Serum Selenium in Cigarette Smokers and the Lack of Association with Lung and Prostate Cancer Risk. Cancer Epidemiol Biomarkers Prev. 10, 1069-1076 (2001).
34. Cui, Y., Vogt, S., Olson, N., Glass, A. G., Rohan, T. E. Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer. Cancer Epidemiol Biomarkers Prev. 16, 1682-1685 (2007).
35. van T, V. P., van der Wielen, R. P., Kok, F. J., Hermus, R. J., Sturmans, F. Selenium in Diet, Blood, and Toenails in Relation to Breast Cancer: A Case-Control Study. Am J Epidemiol. 131, 987-994 (1990).
36. Vinceti, M., Crespi, C. M., Malagoli, C., Del, G. C., Krogh, V. Friend Or Foe The Current Epidemiologic Evidence On Selenium and Human Cancer Risk. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 31, 305-341 (2013).
37. Bleys, J., Navas-Acien, A., Guallar, E. Serum Selenium Levels and All-Cause, Cancer, and Cardiovascular Mortality Among US Adults. Arch Intern Med. 168, 404-410 (2008).
38. Akbaraly, N. T. et al. Selenium and Mortality in the Elderly: Results From the EVA Study. Clin Chem. 51, 2117-2123 (2005).
39. Kornitzer, M., Valente, F., De Bacquer, D., Neve, J., De Backer, G. Serum Selenium and Cancer Mortality: A Nested Case-Control Study within an Age-and Sex-Stratified Sample of the Belgian Adult Population. Eur J Clin Nutr. 58, 98-104 (2004).
40. Ujiie, S., Kikuchi, H. The Relation Between Serum Selenium Value and Cancer in Miyagi, Japan: 5-Year Follow Up Study. Tohoku J Exp Med. 196, 99-109 (2002).
41. Persson-Moschos, M. E., Stavenow, L., Akesson, B., Lindgarde, F. Selenoprotein P in Plasma in Relation to Cancer Morbidity in Middle-Aged Swedish Men. Nutr Cancer. 36, 19-26 (2000).
42. Harris, H. R., Bergkvist, L., Wolk, A. Selenium Intake and Breast Cancer Mortality in a Cohort of Swedish Women. Breast Cancer Res Treat. 134, 1269-1277 (2012).
43. Rejali, L., Jaafar, M. H., Ismail, N. H. Serum Selenium Level and Other Risk Factors for Breast Cancer Among Patients in a Malaysian Hospital. Environ Health Prev Med. 12, 105-110 (2007).
44. Hardell, L. et al. Levels of Selenium in Plasma and Glutathione Peroxidase in Erythrocytes and the Risk of Breast Cancer. A Case-Control Study. Biol Trace Elem Res. 36, 99-108 (1993).
45. Pan, S. Y., Zhou, J., Gibbons, L., Morrison, H., Wen, S. W. Antioxidants and Breast Cancer Risk-a Population-Based Case-Control Study in Canada. Bmc Cancer. 11, 372 (2011).
46. Singh, P., Kapil, U., Shukla, N. K., Deo, S., Dwivedi, S. N. Association Between Breast Cancer and Vitamin C, Vitamin E and Selenium Levels: Results of a Case-Control Study in India. Asian Pac J Cancer Prev. 6, 177-180 (2005).
47. Mannisto, S. et al. Toenail Selenium and Breast Cancer-A Case-Control Study in Finland. Eur J Clin Nutr. 54, 98-103 (2000).
48. Dorgan, J. F. et al. Relationships of Serum Carotenoids, Retinol, Alpha-Tocopherol, and Selenium with Breast Cancer Risk: Results From a Prospective Study in Columbia, Missouri (United States). Cancer Causes Control. 9, 89-97 (1998).
49. Strain, J. J. et al. Thyroid Hormones and Selenium Status in Breast Cancer. Nutr Cancer. 27, 48-52 (1997).
50. van T, V. P. et al. Tissue Antioxidants and Postmenopausal Breast Cancer: The European Community Multicentre Study On Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidemiol Biomarkers Prev. 5, 441-447 (1996).
51. van den Brandt, P. A. et al. Toenail Selenium Levels and the Risk of Breast Cancer. Am J Epidemiol. 140, 20-26 (1994).
52. Jaworska, K. et al. A Low Selenium Level is Associated with Lung and Laryngeal Cancers. Plos One. 8, e59051 (2013).
53. Gromadzinska, J., Wasowicz, W., Rydzynski, K., Szeszenia-Dabrowska, N. Oxidative-Stress Markers in Blood of Lung Cancer Patients Occupationally Exposed to Carcinogens. Biol Trace Elem Res. 91, 203-215 (2003).
54. Hartman, T. J. et al. Toenail Selenium Concentration and Lung Cancer in Male Smokers (Finland). Cancer Causes Control. 13, 923-928 (2002).
55. Knekt, P., Marniemi, J., Teppo, L., Heliovaara, M., Aromaa, A. Is Low Selenium Status a Risk Factor for Lung Cancer Am J Epidemiol. 148, 975-982 (1998).
56. van den Brandt, P. A. et al. A Prospective Cohort Study On Selenium Status and the Risk of Lung Cancer. Cancer Res. 53, 4860-4865 (1993).
57. Jablonska, E., Gromadzinska, J., Sobala, W., Reszka, E., Wasowicz, W. Lung Cancer Risk Associated with Selenium Status is Modified in Smoking Individuals by Sep15 Polymorphism. Eur J Nutr. 47, 47-54 (2008).
58. Ratnasinghe, D. et al. Serum Tocopherols, Selenium and Lung Cancer Risk Among Tin Miners in China. Cancer Causes Control. 11, 129-135 (2000).
59. Cai, L. et al. Dietary Selenium Intake, Aldehyde Dehydrogenase-2 and X-ray Repair Cross-Complementing 1 Genetic Polymorphisms, and the Risk of Esophageal Squamous Cell Carcinoma. Cancer-Am Cancer Soc. 106, 2345-2354 (2006).
60. Takata, Y. et al. Serum Selenium, Genetic Variation in Selenoenzymes, and Risk of Colorectal Cancer: Primary Analysis From the Women's Health Initiative Observational Study and Meta-Analysis. Cancer Epidemiol Biomarkers Prev. 20, 1822-1830 (2011).
61. Connelly-Frost, A. et al. Selenium, Folate, and Colon Cancer. Nutr Cancer. 61, 165-178 (2009).
62. Nelson, R. L. et al. Serum Selenium and Colonic Neoplastic Risk. Dis Colon Rectum. 38, 1306-1310 (1995).
63. Schober, S. E. et al. Serologic Precursors of Cancer. I. Prediagnostic Serum Nutrients and Colon Cancer Risk. Am J Epidemiol. 126, 1033-1041 (1987).
64. Hotaling, J. M. et al. Long-Term Use of Supplemental Vitamins and Minerals Does Not Reduce the Risk of Urothelial Cell Carcinoma of the Bladder in the Vitamins and Lifestyle Study. J Urol. 185, 1210-1215 (2011).
65. Wallace, K. et al. Selenium and Risk of Bladder Cancer: A Population-Based Case-Control Study. Cancer Prev Res (Phila). 2, 70-73 (2009).
66. Kellen, E., Zeegers, M., Buntinx, F. Selenium is Inversely Associated with Bladder Cancer Risk: A Report From the Belgian Case-Control Study On Bladder Cancer. Int J Urol. 13, 1180-1184 (2006).
67. Michaud, D. S., De Vivo, I., Morris, J. S., Giovannucci, E. Toenail Selenium Concentrations and Bladder Cancer Risk in Women and Men. Br J Cancer. 93, 804-806 (2005).
68. Zeegers, M. P., Goldbohm, R. A., Bode, P., van den Brandt, P. A. Prediagnostic Toenail Selenium and Risk of Bladder Cancer. Cancer Epidemiol Biomarkers Prev. 11, 1292-1297 (2002).
69. Michaud, D. S. et al. No Association Between Toenail Selenium Levels and Bladder Cancer Risk. Cancer Epidemiol Biomarkers Prev. 11, 1505-1506 (2002).
70. Helzlsouer, K. J., Comstock, G. W., Morris, J. S. Selenium, Lycopene, Alpha-Tocopherol, Beta-Carotene, Retinol, and Subsequent Bladder Cancer. Cancer Res. 49, 6144-6148 (1989).
71. Lotan, Y. et al. Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT. J Urol. 187, 2005-2010 (2012).
72. Geybels, M. S., Verhage, B. A., van Schooten, F. J., Goldbohm, R. A., van den Brandt, P. A. Advanced Prostate Cancer Risk in Relation to Toenail Selenium Levels. J Natl Cancer Inst. 105, 1394-1401 (2013).
73. Grundmark, B., Zethelius, B., Garmo, H., Holmberg, L. Serum Levels of Selenium and Smoking Habits at Age 50 Influence Long Term Prostate Cancer Risk; A 34 Year ULSAM Follow-Up. Bmc Cancer. 11, 431 (2011).
74. Steinbrecher, A. et al. Effects of Selenium Status and Polymorphisms in Selenoprotein Genes On Prostate Cancer Risk in a Prospective Study of European Men. Cancer Epidemiol Biomarkers Prev. 19, 2958-2968 (2010).
75. Gill, J. K. et al. Association of Selenium, Tocopherols, Carotenoids, Retinol, and 15-Isoprostane F(2t) in Serum Or Urine with Prostate Cancer Risk: The Multiethnic Cohort. Cancer Causes Control. 20, 1161-1171 (2009).
76. Allen, N. E. et al. Plasma Selenium Concentration and Prostate Cancer Risk: Results From the European Prospective Investigation Into Cancer and Nutrition (EPIC). Am J Clin Nutr. 88, 1567-1575 (2008).
77. Pourmand, G. et al. Serum Selenium Level and Prostate Cancer: A Case-Control Study. Nutr Cancer. 60, 171-176 (2008).
78. Peters, U. et al. Vitamin E and Selenium Supplementation and Risk of Prostate Cancer in the Vitamins and Lifestyle (VITAL) Study Cohort. Cancer Causes Control. 19, 75-87 (2008).
79. Peters, U. et al. Serum Selenium and Risk of Prostate Cancer-A Nested Case-Control Study. Am J Clin Nutr. 85, 209-217 (2007).
80. Li, H. et al. A Prospective Study of Plasma Selenium Levels and Prostate Cancer Risk. J Natl Cancer Inst. 96, 696-703 (2004).
81. Lipsky, K. et al. Selenium Levels of Patients with Newly Diagnosed Prostate Cancer Compared with Control Group. Urology. 63, 912-916 (2004).
82. Allen, N. E., Morris, J. S., Ngwenyama, R. A., Key, T. J. A Case-Control Study of Selenium in Nails and Prostate Cancer Risk in British Men. Br J Cancer. 90, 1392-1396 (2004).
83. van den Brandt, P. A., Zeegers, M. P., Bode, P., Goldbohm, R. A. Toenail Selenium Levels and the Subsequent Risk of Prostate Cancer: A Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 12, 866-871 (2003).
84. Duffield-Lillico, A. J. et al. Selenium Supplementation, Baseline Plasma Selenium Status and Incidence of Prostate Cancer: An Analysis of the Complete Treatment Period of the Nutritional Prevention of Cancer Trial. Bju Int. 91, 608-612 (2003).
85. Brooks, J. D. et al. Plasma Selenium Level Before Diagnosis and the Risk of Prostate Cancer Development. J Urol. 166, 2034-2038 (2001).
86. Helzlsouer, K. J. et al. Association Between Alpha-Tocopherol, Gamma-Tocopherol, Selenium, and Subsequent Prostate Cancer. J Natl Cancer Inst. 92, 2018-2023 (2000).
87. Nomura, A. M., Lee, J., Stemmermann, G. N., Combs, G. J. Serum Selenium and Subsequent Risk of Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 9, 883-887 (2000).
88. Hartman, T. J. et al. The Association Between Baseline Vitamin E, Selenium, and Prostate Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev. 7, 335-340 (1998).
89. Yoshizawa, K. et al. Study of Prediagnostic Selenium Level in Toenails and the Risk of Advanced Prostate Cancer. J Natl Cancer Inst. 90, 1219-1224 (1998).
90. Hardell, L., Degerman, A., Tomic, R., Marklund, S. L., Bergfors, M. Levels of Selenium in Plasma and Glutathione Peroxidase in Erythrocytes in Patients with Prostate Cancer Or Benign Hyperplasia. Eur J Cancer Prev. 4, 91-95 (1995).
91. West, D. W., Slattery, M. L., Robison, L. M., French, T. K., Mahoney, A. W. Adult Dietary Intake and Prostate Cancer Risk in Utah: A Case-Control Study with Special Emphasis On Aggressive Tumors. Cancer Causes Control. 2, 85-94 (1991).
92. Hurst, R. et al. Selenium and Prostate Cancer: Systematic Review and Meta-Analysis. Am J Clin Nutr. 96, 111-122 (2012).
93. Reid, M. E. et al. The Nutritional Prevention of Cancer: 400 Mcg Per Day Selenium Treatment. Nutr Cancer. 60, 155-163 (2008).
94. Burk, R. F., Hill, K. E., Motley, A. K. Selenoprotein Metabolism and Function: Evidence for More than One Function for Selenoprotein P. J NUTR. 133, 1517S-1520S (2003).
95. Ou, Y., Jiang, B., Wang, X., Ma, W., Guo, J. Selenium and Colorectal Adenomas Risk: A Meta-Analysis. Nutr Cancer. 64, 1153-1159 (2012).
96. Amaral, A. F., Cantor, K. P., Silverman, D. T., Malats, N. Selenium and Bladder Cancer Risk: A Meta-Analysis. Cancer Epidemiol Biomarkers Prev. 19, 2407-2415 (2010).
97. Korotkov, K. V., Kumaraswamy, E., Zhou, Y., Hatfield, D. L., Gladyshev, V. N. Association Between the 15-kDa Selenoprotein and UDP-glucose: Glycoprotein Glucosyltransferase in the Endoplasmic Reticulum of Mammalian Cells. J Biol Chem. 276, 15330-15336 (2001).
98. Whanger, P. D. Selenium and its Relationship to Cancer: An Update. Br J Nutr. 91, 11-28 (2004).
99. Stranges, S. et al. Effects of Long-Term Selenium Supplementation On the Incidence of Type 2 Diabetes: A Randomized Trial. Ann Intern Med. 147, 217-223 (2007).